Effects of anti-platelet agents on the patients after surgery of the pancreatic cancer as the adjuvant therapy (pilot study)

Effects of anti-platelet agents on the patients after surgery of the pancreatic cancer as the adjuvant therapy (pilot study) - Effects of anti-platelet agents on the pancreatic cancer after surgery

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002971

Enrollment

Registered

2010-01-15

Start date

2010-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

with aspirin without aspirin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: after the curative resection of the pancreatic cancer

Exclusion criteria

Exclusion criteria: metastasis, inoperable cases

Design outcomes

Primary

Measure	Time frame
Disease-free survival	—

Secondary

Measure	Time frame
Overall survival	—

Countries

Japan

Contacts

Public ContactMinoru Kitago

Department of Surgery, Keio University School of Medicine Department of Surgery

03-3353-1211(ext62529)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026